**Background:** Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disorder and the fourth leading cause of mortality worldwide. Patients with COPD frequently experience abnormal nutritional status and body composition changes, including malnutrition and sarcopenia. Malnutrition-sarcopenia syndrome (MSS), the coexistence of both conditions, increases mortality risk more than either alone. While previous studies have examined these conditions separately, limited research has used recent diagnostic standards (GLIM and EWGSOP2) to assess both simultaneously. This study aimed to determine the prevalence of malnutrition, sarcopenia, and MSS in hospitalized COPD patients and their association with disease severity.
**Methods:** This hospital-based analytical cross-sectional study was conducted at a tertiary care hospital in Jamnagar, Gujarat, India, from January to March 2023. A total of 160 hospitalized COPD patients without acute exacerbation were enrolled (mean age 48±5 years; 56.2% male). Data were collected using a self-structured questionnaire covering sociodemographics, clinical profiles, anthropometrics, and bioimpedance indices. Sarcopenia was diagnosed per EWGSOP2 recommendations using low muscle strength (handgrip <27 kg for men, <20 kg for women) and low muscle mass (skeletal muscle mass index <7.0 kg/m² for men, <5.5 kg/m² for women) measured by bioelectrical impedance analysis (BIA). Malnutrition risk was assessed using the Mini Nutritional Assessment-Short Form (MNA-SF) and confirmed by GLIM criteria (phenotypic: weight loss >5% in 6 months, low BMI <20 kg/m² if <70 years or <22 kg/m² if ≥70 years, low muscle mass; etiologic: reduced food intake or disease burden/inflammation). COPD severity was measured using the COPD Assessment Test (CAT), with scores ≥10 indicating symptomatic COPD. Statistical analysis included bivariate comparisons (Student's t-test, Mann-Whitney) and multivariate logistic regression adjusting for age, sex, and BMI, with outcomes of prolonged length of stay (LOS >10 days), readmission within 6 months, and CAT score ≥10.
**Key Results:** The prevalence of sarcopenia was 61.9% (n=99), malnutrition was 45.6% (n=73), and MSS was 32.5% (n=52). Exclusive malnutrition occurred in 13.1% (n=21), exclusive sarcopenia in 29.4% (n=47), and 25% (n=40) had neither condition. Patients with sarcopenia had significantly lower body weight (48.64±11 vs. 59.41±10.5 kg, p<0.001), BMI (18.86±5.11 vs. 23.37±4.71 kg/m², p<0.001), fat-free mass (18.2±4.5 vs. 23.5±4.6 kg, p<0.05), SMMI (5±0.8 vs. 19.98±4.1 kg/m², p<0.001), handgrip strength (7.67±6.7 vs. 13.13±13.07 kg, p<0.001), and MNA-SF scores (8±2.4 vs. 11±2.5, p<0.05) compared to non-sarcopenic patients. Similarly, patients with malnutrition had significantly lower body weight (43.28±5.87 vs. 61.02±10.40 kg, p<0.001), BMI (16.5±2.38 vs. 24±4.32 kg/m², p<0.001), FFM (15.5±4.7 vs. 22.9±5.2 kg, p<0.05), SMMI (6.79±4.35 vs. 14.62±8.34 kg/m², p<0.001), handgrip (7.12±7.90 vs. 11.95±11.08 kg, p=0.008), and MNA-SF (9.2±3.2 vs. 12.5±2.5, p<0.05). MSS patients showed similar significant differences. Multivariate logistic regression revealed that malnutrition was associated with 2.35 times higher odds of prolonged LOS (OR=2.35, p=0.024), 2.45 times higher odds of readmission (OR=2.45, p=0.009), and 2.17 times higher odds of CAT ≥10 (OR=2.17, p=0.021). Sarcopenia showed stronger associations: OR=3.68 (p=0.004) for prolonged LOS, OR=3.92 (p=0.001) for readmission, and OR=2.80 (p=0.005) for CAT ≥10. MSS was associated with OR=2.72 (p=0.004) for prolonged LOS, OR=1.98 (p=0.04) for readmission, and OR=2.08 (p=0.029) for CAT ≥10.
**Clinical Implications:** This study demonstrates a high prevalence of sarcopenia, malnutrition, and MSS in hospitalized COPD patients, with sarcopenia showing the strongest independent associations with adverse outcomes. These findings underscore the importance of routine screening for these conditions using standardized criteria (EWGSOP2 and GLIM) in COPD management. The results suggest that sarcopenia may be a particularly critical target for intervention, potentially through exercise and pharmacological strategies, while malnutrition requires nutritional support. A multidisciplinary approach involving pulmonologists, dietitians, and physiotherapists is recommended. Limitations include the cross-sectional design (precluding causal inference), single-center setting, and relatively small sample size. Future longitudinal studies and intervention trials are needed to establish temporal relationships and optimize treatment strategies.